In PCa, both clinical and experimental studies have revealed the elevated expressions of STAT3 and its target genes in clinical samples, which are positively correlated with the aggressiveness and frequency of the metastasis in patients10,11. The gene discussed is STAT3; the disease is posterior cortical atrophy.